BURNABY, BC, Oct. 6 /CNW/ - Welichem Biotech Inc. (the "Company") (TSX-V:
WBI), announced that Dr. Yeyan Zhang has resigned as a director of the Company
for personal reasons. The Company has greatly valued Dr. Yeyan Zhang's
contribution as a director of the Company for the past few years.
About Welichem Biotech Inc.
---------------------------
Welichem Biotech Inc. is a publicly-traded biotechnology company
developing therapeutic drugs in the fields of autoimmune diseases and cancer.
ON BEHALF OF THE BOARD
Genhui Chen
Chief Executive Officer
The TSX Venture Exchange has not reviewed and does not accept
responsibility for the adequacy or accuracy of the content of this news
release. This press release contains forward-looking statements that include
our belief as to the potential of our products. Certain risks and
uncertainties such as our ability to successfully commercialize the products
could cause the Company's actual results to differ materially from those in
the forward-looking statements.
%SEDAR: 00021386E
